# OnCo record nct04083599 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04083599/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04083599", "NCT04083599" ;
  schema:name "GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Pembrolizumab, Cisplatin, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Genmab, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04083599/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04083599> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2019-09-17" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/head-and-neck/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/flot/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/genmab/> .